STEVE HARRIS

Chairman, Synchrony Pharma

Prior to co-founding Circassia, he was a founding member of the private equity backed management team that grew Zeneus Pharma Limited into a successful specialty pharmaceutical company and managed its acquisition by Cephalon Inc. (now part of Teva Pharmaceutical Industries Limited). Prior to this he served for seven years as Chief Financial Officer of PowderJect Pharmaceuticals plc and was a key member of the management team which grew the organisation from a private biotechnology company to a publicly listed one and transformed it into the world’s fifth largest vaccines business, before it was acquired by Chiron Corporation in 2003.

Steven is Chairman of Synchrony, a generics business which he helped establish, focussed on difficult to make injectables. He is a Chartered Accountant and a member of the Institute of Chartered Accountants of England and Wales (ICAEW).